13d
Zacks Small Cap Research on MSNMGRM: Monogram Receives Clearance from the FDA on its 510(k) Submission for its mBôs TKA System.MGRM READ THE FULL MGRM RESEARCH REPORT On March 17, 2025, Monogram (NASDAQ:MGRM) announced that the FDA has granted 510(k) clearance for its Monogram mBôs TKA System. This determination means that ...
Market the Monogram mBôsâ„¢ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act).
Ben Sexson, Monogram Chief Executive Officer, commented, "This FDA 510(k) clearance is a defining moment for Monogram. It marks the culmination of years of relentless effort, innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results